Immunology and Biotherapies
47.4K views | +4 today
Immunology and Biotherapies
Page Ressources et Actualités du DIU immunologie et biothérapies
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
August 1, 2013 3:25 PM
Scoop.it!

PharmAthene, Theraclone Agree to Merger - Genetic Engineering News

PharmAthene, Theraclone Agree to Merger - Genetic Engineering News | Immunology and Biotherapies | Scoop.it
From www.genengnews.com - August 1, 2013 10:21 AM
PharmAthene, Theraclone Agree to Merger Genetic Engineering News PharmAthene is merging with Theraclone Sciences to create a combined company focused on developing vaccines against infectious diseases and human monoclonal antibody (mAb) drugs...
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
July 28, 2013 11:11 AM
Scoop.it!

Vaccines and therapies against botulism | VaccineOrb | Elsevier

Vaccines and therapies against botulism | VaccineOrb | Elsevier | Immunology and Biotherapies | Scoop.it
From www.vaccineorb.com - July 28, 2013 9:15 AM
Vaccines and therapies against botulism: funding (Vaccines and therapies against botulism (Awarded grant: USD 447k)
http://t.co/oXsGFoywov)
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
July 9, 2013 8:08 AM
Scoop.it!

'Cancer Vaccines', London, UK - Cordis News

From cordis.europa.eu - July 8, 2013 9:32 AM
'Cancer Vaccines', London, UK
Cordis News
Areas of discussion include vaccine design, immunology in addition to clinical data.
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
July 4, 2013 2:35 PM
Scoop.it!

GAPVAC aims to develop personalized therapeutic vaccines for cancer - News-Medical.net

From www.news-medical.net - July 4, 2013 4:17 AM
GAPVAC aims to develop personalized therapeutic vaccines for cancer
News-Medical.net
The clinical trial will be led by chief investigator Prof. Dr. Wolfgang Wick, University of Heidelberg, and co-led by Prof.
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
July 2, 2013 1:25 PM
Scoop.it!

Boosting immunity - and vaccine research - Cordis News

Boosting immunity - and vaccine research - Cordis News | Immunology and Biotherapies | Scoop.it
From cordis.europa.eu - July 1, 2013 9:13 AM
Boosting immunity - and vaccine research
Cordis News
As well as our innate immune system, our bodies have the ability to acquire immunity to specific pathogens - and this is what vaccines are designed to achieve.
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
June 13, 2013 2:33 PM
Scoop.it!

Sanofi's Quadrivalent Fluzone to Earn Up to $384m by 2022, says GlobalData - PharmaLive (press release) (subscription)

Sanofi's Quadrivalent Fluzone to Earn Up to $384m by 2022, says GlobalData - PharmaLive (press release) (subscription) | Immunology and Biotherapies | Scoop.it
From www.pharmalive.com - June 12, 2013 2:44 PM
Sanofi's Quadrivalent Fluzone to Earn Up to $384m by 2022, says GlobalData PharmaLive (press release) (subscription) “In addition to new formulations, the future of influenza vaccines also rests on the success of novel routes of administration that...
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
June 5, 2013 9:46 AM
Scoop.it!

PCT inks manufacturing agreement with IMUC for dendritic cell vaccines ... - pharmabiz.com

From www.pharmabiz.com - June 5, 2013 5:43 AM
PCT inks manufacturing agreement with IMUC for dendritic cell vaccines ...
pharmabiz.com
Progenitor Cell Therapy LLC (PCT), a subsidiary of NeoStem, Inc., and ImmunoCellular Therapeutics, Ltd.
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
May 17, 2013 9:01 AM
Scoop.it!

Frontiers | Skin-resident antigen-presenting cells: Instruction manual for vaccine development | Frontiers in Immunotherapies and Vaccines

Frontiers | Skin-resident antigen-presenting cells: Instruction manual for vaccine development | Frontiers in Immunotherapies and Vaccines | Immunology and Biotherapies | Scoop.it
From www.frontiersin.org - May 17, 2013 8:43 AM
Frontiers | Skin-resident antigen-presenting cells: Instruction manual for vaccine development | Frontiers in Immunotherapies and Vaccines publishes articles on the most outstanding discoveries across the research spectrum of Frontiers | ...
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
May 1, 2013 9:58 AM
Scoop.it!

Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study | BMJ

Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study | BMJ | Immunology and Biotherapies | Scoop.it
From www.bmj.com - May 1, 2013 3:29 AM
AbstractObjectives To estimate uptake of the combined measles, mumps, and rubella vaccine (MMR) and single antigen vaccines and explore factors associated with uptake and reasons for not using MMR.Design Nationally representative cohort...
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
April 7, 2013 4:03 AM
Scoop.it!

Virology Journal | Abstract | Comparison of polystyrene ...

From www.virologyj.com - April 4, 2013 8:00 PM
Inert nanoparticles are attracting attention as carriers for protein-based vaccines. Here we evaluate the immunogenicity of the model antigen ovalbumin delivered on polystyrene particles and directly compare particulate ...
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
April 1, 2013 6:25 AM
Scoop.it!

Scripps Research-led study may improve HIV, flu vaccines - U-T San Diego

Scripps Research-led study may improve HIV, flu vaccines - U-T San Diego | Immunology and Biotherapies | Scoop.it
From www.utsandiego.com - March 29, 2013 8:57 PM
Scripps Research-led study may improve HIV, flu vaccines
U-T San Diego
This graphic shows how the computer-designed protein, in red, binds to a broadly neutralizing antibody against HIV called VRC01, in magenta and yellow.
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
March 15, 2013 4:18 AM
Scoop.it!

Common Cancer Vaccine Ingredient Diverts T Cells From Tumors

Common Cancer Vaccine Ingredient Diverts T Cells From Tumors | Immunology and Biotherapies | Scoop.it
From www.medicalnewstoday.com - March 15, 2013 3:14 AM
Cancer vaccines that attempt to stimulate an immune system assault fail because the killer T cells aimed at tumors instead find the vaccination site a more inviting target, scientists at The Unive (RT @AlexBevard: Common Cancer Vaccine Ingredient ...
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
February 20, 2013 11:02 AM
Scoop.it!

Q&A: Inovio CEO on DNA Vaccines - Wall Street Journal- India (blog)

Q&A: Inovio CEO on DNA Vaccines - Wall Street Journal- India (blog) | Immunology and Biotherapies | Scoop.it
From blogs.wsj.com - February 19, 2013 9:30 PM
Q&A: Inovio CEO on DNA Vaccines
Wall Street Journal- India (blog)
Many of its vaccines – for cancers, leukemia, hepatitis C and other diseases — are in mid-stage clinical testing phases. Inovio Chief ...
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
July 31, 2013 12:55 PM
Scoop.it!

Frontiers | Vaccine Adjuvants: Mode of Action | Frontiers in Immunotherapies and Vaccines

Frontiers | Vaccine Adjuvants: Mode of Action | Frontiers in Immunotherapies and Vaccines | Immunology and Biotherapies | Scoop.it
From www.frontiersin.org - July 31, 2013 7:55 AM
Frontiers | Vaccine Adjuvants: Mode of Action | Frontiers in Immunotherapies and Vaccines publishes articles on the most outstanding discoveries across the research spectrum of Frontiers | Vaccine Adjuvants: Mode of Action | Immunotherapies and...
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
July 27, 2013 3:15 AM
Scoop.it!

Frontiers | IFN Signaling: How a Non-Canonical Model Led to the Development of IFN Mimetics | Frontiers in Immunotherapies and Vaccines

Frontiers | IFN Signaling: How a Non-Canonical Model Led to the Development of IFN Mimetics | Frontiers in Immunotherapies and Vaccines | Immunology and Biotherapies | Scoop.it
From www.frontiersin.org - July 27, 2013 2:18 AM
Frontiers | IFN Signaling: How a Non-Canonical Model Led to the Development of IFN Mimetics | Frontiers in Immunotherapies and Vaccines publishes articles on the most outstanding discoveries across the research spectrum of Frontiers | IFN...
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
July 6, 2013 10:26 AM
Scoop.it!

EU supports GAPVAC with €6 million to develop fully personalized vaccines for ... - pharmabiz.com

From www.pharmabiz.com - July 6, 2013 1:37 AM
EU supports GAPVAC with €6 million to develop fully personalized vaccines for ...
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
July 4, 2013 8:06 AM
Scoop.it!

Frontiers | Self-Adjuvanting Bacterial Vectors Expressing Pre-Erythrocytic Antigens Induce Sterile Protection Against Malaria | Frontiers in Immunotherapies and Vaccines

Frontiers | Self-Adjuvanting Bacterial Vectors Expressing Pre-Erythrocytic Antigens Induce Sterile Protection Against Malaria | Frontiers in Immunotherapies and Vaccines | Immunology and Biotherapies | Scoop.it
From www.frontiersin.org - July 4, 2013 5:34 AM
Genetically inactivated, Gram-negative bacteria that express malaria vaccine candidates represent a promising novel self-adjuvanting vaccine approach.
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
June 28, 2013 3:15 AM
Scoop.it!

Frontiers | Immunosenescence and Novel Vaccination Strategies for the Elderly | Frontiers in Immunotherapies and Vaccines

Frontiers | Immunosenescence and Novel Vaccination Strategies for the Elderly | Frontiers in Immunotherapies and Vaccines | Immunology and Biotherapies | Scoop.it
From www.frontiersin.org - June 28, 2013 3:07 AM
Frontiers | Immunosenescence and Novel Vaccination Strategies for the Elderly | Frontiers in Immunotherapies and Vaccines publishes articles on the most outstanding discoveries across the research spectrum of Frontiers | Immunosenescence and...
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
June 11, 2013 1:40 PM
Scoop.it!

Phase 1 trial uses enhanced T cells to treat neuroblastoma - BCM News

From www.bcm.edu - June 10, 2013 2:50 PM
Phase 1 trial uses enhanced T cells to treat neuroblastoma
BCM News
The disease is susceptible to antibodies that target the GD2 antigen expressed by the tumor and to T cell immune responses triggered by tumor vaccines.
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
May 27, 2013 6:29 AM
Scoop.it!

Frontiers | Of Creatures Great and Small: The Advantages of Farm Animal Models in Immunology Research | Frontiers in Immunotherapies and Vaccines

Frontiers | Of Creatures Great and Small: The Advantages of Farm Animal Models in Immunology Research | Frontiers in Immunotherapies and Vaccines | Immunology and Biotherapies | Scoop.it
From www.frontiersin.org - May 27, 2013 5:15 AM
Frontiers | Of Creatures Great and Small: The Advantages of Farm Animal Models in Immunology Research | Frontiers in Immunotherapies and Vaccines publishes articles on the most outstanding discoveries across the research spectrum of Frontiers | ...
Read more
more...
No comment yet.
Sign up to comment
Rescooped by Gilbert C FAURE from Virology News
May 11, 2013 7:35 AM
Scoop.it!

Recombinant Monovalent Llama-Derived Antibody Fragments (VHH) to Rotavirus VP6 Protect Neonatal Gnotobiotic Piglets against Human Rotavirus-Induced Diarrhea

Recombinant Monovalent Llama-Derived Antibody Fragments (VHH) to Rotavirus VP6 Protect Neonatal Gnotobiotic Piglets against Human Rotavirus-Induced Diarrhea | Immunology and Biotherapies | Scoop.it
From www.plospathogens.org - May 10, 2013 3:32 AM

This study shows that the oral administration of rotavirus VP6-VHH nanoAb is a broadly reactive and effective treatment against rotavirus-induced diarrhea in neonatal pigs. Our findings highlight the potential value of a broad neutralizing VP6-specific VHH nanoAb as a treatment that can complement or be used as an alternative to the current strain-specific RVA vaccines. Nanobodies could also be scaled-up to develop pediatric medication or functional food like infant milk formulas that might help treat RVA diarrhea.


Via Ed Rybicki
Read more
more...
Ed Rybicki's curator insight, May 10, 2013 3:32 AM

Always nice to Scoop a paper from a co-author, in this case Andres Wigdorovitz and friends.  Nice work, too - shows that rotavirus VP6 is a useful recombinant protein target for use as a vaccine, given that llama single-chain Abs specific to it can protect.  But why not make them in plants, Andres??
Sign up to comment
Scooped by Gilbert C FAURE
April 9, 2013 1:42 PM
Scoop.it!

New anti-CD27 monoclonal antibody adjuvant for pancreatic cancer vaccines | VaccineOrb | Elsevier

New anti-CD27 monoclonal antibody adjuvant for pancreatic cancer vaccines | VaccineOrb | Elsevier | Immunology and Biotherapies | Scoop.it
From www.vaccineorb.com - April 7, 2013 2:51 PM
New anti-CD27 monoclonal antibody adjuvant for pancreatic cancer vaccines: vaccine funding (New anti-CD27 monoclonal antibody adjuvant for pancreatic cancer vaccines (awarded grant) http://t.co/7Y1iWFceww)...
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
April 4, 2013 2:17 PM
Scoop.it!

Frontiers | Variation between Populations in the Innate Immune Response to Vaccine Adjuvants | Frontiers in Immunotherapies and Vaccines

Frontiers | Variation between Populations in the Innate Immune Response to Vaccine Adjuvants | Frontiers in Immunotherapies and Vaccines | Immunology and Biotherapies | Scoop.it
From www.frontiersin.org - April 2, 2013 9:02 AM
Frontiers | Variation between Populations in the Innate Immune Response to Vaccine Adjuvants | Frontiers in Immunotherapies and Vaccines publishes articles on the most outstanding discoveries across the research spectrum of Frontiers | Variation...
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
March 24, 2013 4:24 AM
Scoop.it!

PhRMA: 907 biotech drugs, vaccines under development | Drug Store News

From m.drugstorenews.com - March 23, 2013 9:58 PM
907 new biotech drugs in development: cancer = 338; infectious diseases = 134; autoimmunity = 71; cardiovascular = 58 http://t.co/wL1otg2tbq
Read more
more...
No comment yet.
Sign up to comment
Scooped by Gilbert C FAURE
March 3, 2013 12:32 PM
Scoop.it!

Zapping Pathological Proteins in Alzheimer's - Genetic Engineering News

Zapping Pathological Proteins in Alzheimer's - Genetic Engineering News | Immunology and Biotherapies | Scoop.it
From www.genengnews.com - March 1, 2013 7:09 AM
Zapping Pathological Proteins in Alzheimer's
Genetic Engineering News
AC Immune is fighting Alzheimer's disease on three fronts armed with monoclonal antibodies, vaccines, and small molecules.
Read more
more...
No comment yet.
Sign up to comment
About Follow us Resources Terms Mobile Features
Facebook
X
LinkedIn